Market closed
Surrozen Inc./$SRZN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Ticker
$SRZN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
42
Website
Surrozen Inc. Metrics
BasicAdvanced
$99M
-
-$21.67
-
-
Price and volume
Market cap
$99M
52-week high
$14.00
52-week low
$10.10
Financial strength
Current ratio
5.322
Quick ratio
5.073
Long term debt to equity
-31.057
Total debt to equity
-39.612
Management effectiveness
Return on assets (TTM)
-33.76%
Return on equity (TTM)
-767.91%
Valuation
Price to revenue (TTM)
3.232
Price to book
-1.13
Price to tangible book (TTM)
-1.13
Price to free cash flow (TTM)
-1.95
Growth
Earnings per share change (TTM)
1.61%
3-year earnings per share growth (CAGR)
-13.25%
Surrozen Inc. News
AllArticlesVideos
Insiders Are Loving These 5 Tech and Biotech Stocks
24/7 Wall Street·3 days ago
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewsWire·5 days ago
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Surrozen Inc. stock?
Surrozen Inc. (SRZN) has a market cap of $99M as of April 05, 2025.
What is the P/E ratio for Surrozen Inc. stock?
The price to earnings (P/E) ratio for Surrozen Inc. (SRZN) stock is 0 as of April 05, 2025.
Does Surrozen Inc. stock pay dividends?
No, Surrozen Inc. (SRZN) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Surrozen Inc. dividend payment date?
Surrozen Inc. (SRZN) stock does not pay dividends to its shareholders.
What is the beta indicator for Surrozen Inc.?
Surrozen Inc. (SRZN) does not currently have a Beta indicator.